CHGA — Change Agents Share News
0.000.00%
Brief: Avalon Globocare Files For Mixed Shelf Of Up To $100 Mln - SEC Filing
Brief: Avalon Globocare Advances Proposed Merger With Yoov With Filing Of Registration Statement
Brief: Avalon Globocare Announces Issuance Of Patent In China
Brief: Avalon Globocare and Yoov to merge
Brief: Avalon Receives Notice Of Allowance For CAR-T and CAR-NK Cell Technology In China
Brief: Avalon Globocare Launches “Brace For Impact" Affiliate Marketing Program For The Ketoair Breathalyzer Device
Brief: Avalon Globocare Launches Online Sales Of Ketoair Breathalyzer In U.S.
Brief: Avalon Globocare Says Co Got Letter From Nasdaq Advising It Was Granted 180-Day Extension To Oct 28, To Regain Compliance With Min Bid Price Requirement
Brief: Avalon Globocare Expects To Report Material Weakness In Its Internal Controls Over Financial Reporting And Its Disclosure Controls And Procedures
Brief: Avalon GloboCare Extends Exclusivity Agreement To Distribute KetoAir Breathalyzer Device, AI-Enabled Software
Brief: Avalon Globocare Corp, On November 3, Received Notice From Nasdaq That Co Does Not Satisfy Minimum Bid Price Requirement
Brief: Avalon's Laboratory Services Acquires A Medical Supply Company And Proprietary FDA-Registered External Male Catheter Device
Brief: Avalon’s Laboratory Services MSO Acquires Texas Lab
Brief: Avalon GloboCare's Laboratory Services MSO Signs Exclusive Agreement Providing Expansion Opportunity Into 21 States
Brief: Avalon Globocare Provides Update On New Commercial Strategy
Brief: Avalon Globocare Files For Mixed Shelf Offering Of Up To $100 Mln
Brief: Avalon Globocare Enters Into Certain Sales Agreement With Roth Capital Partners
Brief: Avalon Globocare Says Expects To Report Material Weaknesses In Its Internal Controls Over Financial Reporting And Its Disclosure Controls And Procedures
Brief: Avalon Globocare Signs Distribution Agreement With Qi Diagnostics